The Venture Codex Logo

The Venture Codex

Patient Square Capital

2884 Sand Hill Road, Suite 100, Menlo Park, CA, 94025, United States

Overview

Healthcare investment firm partnering with management teams for improvement

Founded

2020

Deals ยท 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

Germany
United Kingdom
United States

Sector focus

Finance
Financial Services
Health Care

Investment portfolio

10rounds
NAMEDATESIZE
Osanni Bio
Jun 2026Led
$190 MSeries B
Ambros Therapeutics
Dec 2025Led
$125 MSeries A
Kriya Therapeutics
Sep 2025Led
$320 MSeries D
Nuclera
Oct 2024Participated
$77 MSeries C
Apollo Therapeutics
Jan 2024Led
$34 MSeries C
Kriya Therapeutics
Aug 2023Led
$150 MSeries C
Resolve BioSciences
Oct 2022Led
$71 MSeries B
Kriya Therapeutics
May 2022Led
$270 MSeries C
Kriya Therapeutics
Jul 2021Led
$100 MSeries B
Apollo Therapeutics
Jun 2021Led
$139 MOther Equity
Osanni Bio
Jun 2026Led
$190 MSeries B
Ambros Therapeutics
Dec 2025Led
$125 MSeries A
Kriya Therapeutics
Sep 2025Led
$320 MSeries D
Nuclera
Oct 2024Participated
$77 MSeries C
Apollo Therapeutics
Jan 2024Led
$34 MSeries C
Kriya Therapeutics
Aug 2023Led
$150 MSeries C
Resolve BioSciences
Oct 2022Led
$71 MSeries B
Kriya Therapeutics
May 2022Led
$270 MSeries C
Kriya Therapeutics
Jul 2021Led
$100 MSeries B
Apollo Therapeutics
Jun 2021Led
$139 MOther Equity
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Patient Square Capital: 10 funding rounds are recorded in the selected participation categories.All available history.
Patient Square Capital: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B30
Series C+41
Other Equity10

Monthly Deal Activity

Patient Square Capital: 10 deals are recorded across 65 months.All available history.
Patient Square Capital: 10 deals are recorded across 65 months. All available history
MonthDeals
Jun '211
Jul '211
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Patient Square Capital: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Patient Square Capital: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
Space & Frontier Tech4

Deal Size Distribution

Patient Square Capital: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Patient Square Capital: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M2
$100M-$250M5
$250M-$500M2
$500M-$1B0
$1B+0

Deals By Geography

Patient Square Capital: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Patient Square Capital: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
Europe4
Patient Square Capital: 20 co-investors are shown, with Narya Capital sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Patient Square Capital: 20 co-investors are shown, with Narya Capital sharing 3 recorded deals. All available history
Co-investorShared deals
Narya Capital3
Transhuman Capital3
Bluebird Ventures2
CAM Capital2
Dexcel Pharma2
Foresite Capital2
JDRF T1D Fund2
QVT2
Rock Springs Capital2
Abiogen Pharma1
Adage Capital Management1
Alafi Capital1
Alumni Ventures1
Amplo1
Arkin Bio Ventures1
Balyasny Asset Management1
British Patient Capital1
Cambridge Innovation Capital1
E Ink1
EDBI1

Investment Strategy

Patient Square Capital: Led accounts for 90% and participating for 10% of round participation.All available history.
Patient Square Capital: Led accounts for 90% and participating for 10% of round participation. All available history
CategoryDeals (count)Share (%)
Led990%
Participating110%
Patient Square Capital: Single-lead accounts for 78% and co-led for 22% of lead dynamics.All available history.
Patient Square Capital: Single-lead accounts for 78% and co-led for 22% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead778%
Co-led222%

Team

Adam Fliss

Founding Partner and General Counsel

Alex Albert

Founding Partner

Karr Narula

Founding Partner

Kaveh Samie

Partner, Chairman and CEO of MENA and Head of International Fund Partnerships

Maria Walker

Founding Partner & Chief Financial Officer

Neel Varshney

Founding Partner

Neel Varshney
Trit Garg

Vice President